rs11280056
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_017512.7(ENOSF1):c.*856_*861delCTTTAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.383 in 217,316 control chromosomes in the GnomAD database, including 17,511 homozygotes. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.39 ( 12782 hom., cov: 0)
Exomes 𝑓: 0.36 ( 4729 hom. )
Consequence
ENOSF1
NM_017512.7 3_prime_UTR
NM_017512.7 3_prime_UTR
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.42
Publications
33 publications found
Genes affected
ENOSF1 (HGNC:30365): (enolase superfamily member 1) This gene can encode a mitochondrial enzyme that is thought to convert L-fuconate to 2-keto-3-deoxy-L-fuconate. This locus was originally identified as the source of antisense RNAs of the adjacent thymidylate synthase gene. Splice variants at this locus may contain an alternate 3' exon that is complementary to the 3'UTR and terminal intron of the thymidylate synthase (TS) RNA and may downregulate TS expression. [provided by RefSeq, Aug 2017]
TYMS (HGNC:12441): (thymidylate synthetase) Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.661 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ENOSF1 | ENST00000647584.2 | c.*856_*861delCTTTAA | 3_prime_UTR_variant | Exon 16 of 16 | NM_017512.7 | ENSP00000497230.2 | ||||
| TYMS | ENST00000323274.15 | c.*450_*455delAAGTTA | 3_prime_UTR_variant | Exon 7 of 7 | 1 | NM_001071.4 | ENSP00000315644.10 |
Frequencies
GnomAD3 genomes AF: 0.395 AC: 59744AN: 151380Hom.: 12769 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
59744
AN:
151380
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.358 AC: 23543AN: 65816Hom.: 4729 AF XY: 0.354 AC XY: 10768AN XY: 30388 show subpopulations
GnomAD4 exome
AF:
AC:
23543
AN:
65816
Hom.:
AF XY:
AC XY:
10768
AN XY:
30388
show subpopulations
African (AFR)
AF:
AC:
1508
AN:
2874
American (AMR)
AF:
AC:
672
AN:
2322
Ashkenazi Jewish (ASJ)
AF:
AC:
1483
AN:
4106
East Asian (EAS)
AF:
AC:
5735
AN:
9064
South Asian (SAS)
AF:
AC:
266
AN:
640
European-Finnish (FIN)
AF:
AC:
14
AN:
56
Middle Eastern (MID)
AF:
AC:
176
AN:
384
European-Non Finnish (NFE)
AF:
AC:
11891
AN:
41016
Other (OTH)
AF:
AC:
1798
AN:
5354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
534
1068
1602
2136
2670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.395 AC: 59790AN: 151500Hom.: 12782 Cov.: 0 AF XY: 0.398 AC XY: 29482AN XY: 74028 show subpopulations
GnomAD4 genome
AF:
AC:
59790
AN:
151500
Hom.:
Cov.:
0
AF XY:
AC XY:
29482
AN XY:
74028
show subpopulations
African (AFR)
AF:
AC:
22575
AN:
41276
American (AMR)
AF:
AC:
5077
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
AC:
1379
AN:
3466
East Asian (EAS)
AF:
AC:
3461
AN:
5090
South Asian (SAS)
AF:
AC:
2139
AN:
4804
European-Finnish (FIN)
AF:
AC:
3168
AN:
10532
Middle Eastern (MID)
AF:
AC:
137
AN:
292
European-Non Finnish (NFE)
AF:
AC:
20869
AN:
67798
Other (OTH)
AF:
AC:
835
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1723
3447
5170
6894
8617
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
562
1124
1686
2248
2810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1997
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.